GRPN Archives - Blue Horseshoe Stocks

GRST, CELZ Recaps & More

OTC Recaps

As we’ve mentioned several times over the last month, we have been supplementing quite a bit of OTC-traded stocks in addition to our routine options watchlists. Here are a couple of movers that we’ve been tracking.

Ethema Health Corp. GRST – We initially alerted on GRST on the morning of June 5th, at which time the stock was trading in the super-subpenny basement at ,0002 a share. Yesterday, the stock attained an impressive new high at .0027. That’s a monster gain of 1250% in a period of just eight trading days, and it adds yet another thousand-percenter to our 2020 track record, which contains several at this point.
_____

Creative Medical Technology Holdings, Inc. CELZ – We put CELZ on our extended watchlist in yesterday’s premarket report, and the stock produced a fairly nice intraday gain on the session.

From a low of .0044, the stock saw a high of .0073, which works out to a 66% rip. If it manages to crack recent resistance at .0075, there;s not a whole lot stopping CELZ from making a run into penny-plus territory.

Fresh Options Ideas:

GRPN Weekly $28-29 Calls & 07/02 $30-31 Calls
SIEB 07/17 $5 Calls
ATAX 07/17 $5 Calls

Special Note: H&R Block stands to see increased business flow over the next month with the tax deadline having been pushed back due to the coronavirus. We’re going to signal the HRB 07/17 $19-20 Calls for a possible swing trade.

Extended Watchlist:
UONEK, CLWD, ATDS, VSMR, AMNP

Blue Horseshoe Stocks: Options Success Continues

OPTIONS REVIEW

First thing’s first today, we’re going to highlight the total possible gains which have resulted from options ideas we’ve posted in our morning reports over the past three trading days.

On Friday morning, we slated the GlaxoSmithKline plc GSK 05/17 $41 Calls for observation, and have seen a very solid increase since then. The $41 Calls were trading as low as .32 the morning of our alert, and yesterday, reached a high of .65. That marks a three-day swing of 103% The company posted an earnings beat this morning, so we’ll continue to monitor for any further potential progress here.
_____

Yesterday morning, we flagged the Seagate Technology plc STX Weekly $46.50-47.50 Calls, and were met with instant good fortune with those ideas. The single-session gains on this set of ideas was excellent:

$46.50 Calls – Range: 1.02-2.25 – Max Gain: 121%
$47 Calls – Range: .75-1.65 – Max Gain: 120%
$47.50 Calls – Range: .75-1.35 – Max Gain: 80%
_____

Lastly, also in yesterday’s report, we had the GE Weekly $10 Calls, and those fared reasonably well also, trading in a daily range from .19-.35 (+84%).
_____

POST-EARNINGS OPTIONS IDEAS:
Apple, Inc. AAPL Weekly $207.50-210 Calls

CVS Corp. CVS Weekly $56-58 Calls

Extended Watchlist:
HEB, OCUL, MTOR, GRPN, SNGX, CRSP. IPHI

Blue Horseshoe Stocks: BLNK, Bottom-Play & More

Blink Charging Co. BLNK

We signaled our interest in BLNK in yesterday morning’s premarket report via the Extended Watchlist, and we’re happy to report on what was a very productive first day of observation.

From a low of 4.34, BLNK made a highly respectable intraday run to 6.34, marking an intraday push of 46% Prior to Monday’s session, wherein the stock picked up in a big way, it had been trading sideways for quite some time. We will be interested in monitoring this play for the possibility of a more sustained uptrend in the days ahead.

Gogo. Inc. GOGO

We want to also bring some attention to the massive selloff which has occurred over the past three trading days. After trading for nearly $10/share, a disappointing earnings release and subsequent Moody’s downgrade has precipitated close to a 50% drop, leaving GOGO trading at just above $5.

We’re going to want to put this one on intensive bottom-watch, as we prepare for possible course correction leading to a bounce play opportunity.

Fresh Options Idea:
Trip Advisor, Inc. TRIP Weekly $45.50 & $46 Calls

Extended Watchlist:
UURAF, TRXC, PLUG, LC, MNKD, GRPN, ICHR, TWLO

Blue Horseshoe Stocks: Reviewing June Winners & More

Moleculin Biotech, Inc. MBRX

We wanted to circle back for an update on MBRX this morning, a stock that we signaled on June 21st, after noticing some abnormal activity the session prior.

Shortly thereafter we would witness a low of .96 in the stock, from which it would never look back. MBRX has been on a multi-day tear, with things really heating up yesterday. It ripped its way to a new high of 3.38, on more than 16 times the monthly average volume. That represents a total rise of 252%

We’ll continue to stay hot on the trail of MBRX for as long as it continues to build higher base levels of support.

Spherix Corp. SPEX

The day before the above-mentioned play, on June 20th, we highlighted SPEX after noticing the stock trading near a bottom, and it has been one heck of a ride since that time. We’ve seen this play run from a low of .9505 all the way up to 2.23.

The bulk of that move came in yesterday’s session wherein the stock also traded massive volume, so we’ll be on the lookout for a possible momentum spillover as we head into week’s end.

TrovaGene Inc. TROV

It was back on June 12th that we initially slated TROV for observation. The stock had been trending up off of recent relative lows since the beginning of this month.

Subsequent to our alert, we would witness a low of .85 in the stock and despite some swing-action, TROV has been in a general uptrend ever since.. As of the new high achieved in this morning’s premarket (1.60) it marks an increase of 88%

Constellation Brands, Inc. STZ – Options Idea

We’ve used the STZ optuions chain to our advantage in the past. The most recent occasion was last April, when we scored multibag gains with $155 Calls. The stock has been in serious growth-mode since then, and with a hearty, untraded-upon Q1 earnings beat this morning, we want to signal a range of contracts to watch once again.

The stock is gapping up to the $200-range today, and we’re going to be waiting in the wings with the STZ 07/21 $190-210 Calls.

Extended Watchlist:
GRPN, CHFS, SPLS, IMNP, LODE, INNMF

Blue Horseshoe Stocks: MNKD, VRX Recaps & More

MannKind Corp. MNKD

We tagged MNKD a week ago today in our premarket report on May 4th, and wanted to circle back around this morning to go over the excellent performance the stock has recorded since then. At the time the stock had been looking like it wanted to rebound after crashing down to a bottom and our decision to mention it turned out to be timed perfectly.

In each of the past five sessions MNKD has registered higher highs and higher lows, continuing to gain back ground that it had lost in previous weeks. From last Thursday’s low of .688, the stock has gone on to reach a high of 1.88, which represents an increase of 173% while volume over the same period has been impressive. The stock traded its highest volume since 2014 yesterday, so we’re really eager to continue tracking the activity in MNKD.

Valeant Pharmaceuticals, Inc. VRX

Despite already showing us amazing single-session gains ranging from 380-3600% on Tuesday, which we recapped in yesterday’s premarket report, our options idea for the VRX chain, the Weekly $10.50-12 Calls saw even further advances once the session kicked off.

We’ve included the total possible intraday gains from yesterday’s session, as well as the overall gains from our observed lows on Tuesday morning.

$10.50 Calls – Daily Range: 1.43-2.36 – Daily Gain: 65% – Total Range: .40-2.36 – Two-Day Swing: 490%
$11 Calls – Daily Range: .92-1.99 – Daily Gain: 116% – Total Range: .18-1.99 – Two-Day Swing: 1005%
$11.50 Calls – Daily Range: .53-1.42 – Daily Gain: 68% – Total Range: .08-1.42 – Two-Day Swing: 1675%
$12 Calls – Daily Range: .29-.99 – Daily Gain: 241% – Total Range: .02-.99 – Two-Day Swing: 4850%

Even though it’s not even close to our only percentage gainer in the thousands, this round of options calls with VRX is certainly going down as one of our most solid picks of the year so far. Even if someone had only bought shares in VRX stock itself, they could have been up just over 22% on this two-day swing.

Groupon, Inc. GRPN

We want to place GRPN on recovery watch after noticing the stock coming up off a double-bottom, with a gap on the chart to fill to the upside, as you can see on the included snapshot.

We like to monitor plays in this position, so we’ll put it on our radars in the days and weeks ahead. Given the look of this chart, we’d classify this as relatively low-risk, low-reward in comparison one of our average plays.

Extended Watchlist:
DEST, LPSN, MSLI, SGMO, SYN, SYMX